Articles about Drugs Controller General of India
20 Aug 2021
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) has recommended granting an emergency use authorization (EUA) to ZyCoV-D, the three-dose COVID-19 vaccine developed by Zydus Cadila, on Friday.
11 Aug 2021
India's drug regulator approves study on mixing Covishield, COVAXIN jabs
The Drugs Controller General of India (DCGI) has approved a proposal to conduct a study on the mixing of Covishield and COVAXIN COVID-19 vaccines.
20 Jul 2021
India offered 7.5mn doses of Moderna vaccine under COVAX program
India has been offered 7.5 million doses of Moderna's COVID-19 vaccine through the COVAX global vaccine sharing program, but it is not clear when the jabs will arrive in the country as a consensus on the indemnity clause is yet to be reached, sources said.
09 Jul 2021
Hetero seeks Emergency Use Authorization for Molnupiravir in India
The use of Molnupiravir, an experimental oral drug having antiviral properties, has resulted in early recovery of COVID-19 patients with mild symptoms when compared to standard treatment during Phase III clinical trials, Hetero said on Friday citing interim data.
08 Jul 2021
DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG
Pharmaceutical firm Mankind Pharma on Thursday announced that it has received approval from the Defence Research and Development Organisation (DRDO) to manufacture and market the COVID-19 drug 2-Deoxy-D-Glucose or 2-DG.
01 Jul 2021
Expert panel says no to Covovax's children trials in India
A Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) has denied permission to Pune-based Serum Institute of India (SII) for conducting clinical trials of its second COVID-19 vaccine, Covovax, in children.
01 Jul 2021
Zydus applies for approval of its 3-dose, needle-free COVID-19 vaccine
Zydus Cadila, the Gujarat-based drug firm, has applied for the Emergency Use Authorization (EUA) of its COVID-19 vaccine to the Drugs Controller General of India (DCGI), the company said today.
22 Jun 2021
Bharat Biotech submits COVAXIN phase-3 trial data, review meet today
Bharat Biotech has submitted the phase three clinical trial data for its coronavirus vaccine COVAXIN to the Drugs Controller General of India (DCGI).
12 Jun 2021
COVID-19: DCGI gives approval for phase-2 clinical trials of Colchicine
India's top drug regulator - the Drugs Controller General of India (DCGI) - has given approval to carry out phase-2 clinical trials of Colchicine on COVID-19 patients.
02 Jun 2021
Foreign COVID-19 vaccines exempted from local trials, batch testing
The Drugs Controller General of India has scrapped the requirement of local trials for foreign-made coronavirus vaccines - a key move to upscale the dwindling COVID-19 vaccinations in the country.
21 May 2021
DRDO's antibody detection kit DIPCOVAN approved by the DCGI
The Drugs Controller General of India (DCGI) has approved an antibody detection kit developed by a laboratory of the Defence Research and Development Organisation (DRDO), reports say.
08 May 2021
DRDO's anti-coronavirus drug cleared for emergency use by DCGI
The Drugs Controller General of India (DCGI) has approved the emergency use of an anti-coronavirus drug developed by a laboratory of the Defence Research and Development Organisation (DRDO) to treat moderate to severe patients, reports say.
05 Feb 2021
Expert panel recommended against granting EUA to Pfizer's vaccine: Officials
Just two days before pharma major Pfizer announced the withdrawal of its application for emergency use authorization of its COVID-19 vaccine in India, an expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage.
20 Jan 2021
Panel recommends permission for Phase I Intranasal COVID-19 vaccine trial
An expert panel, Central Drugs Standard Control Organisation, (CDSCO) on Tuesday recommended granting permission for conducting the Phase I clinical trial of an intranasal vaccine against COVID-19 developed by Bharat Biotech, official sources said.
09 Jan 2021
Days after participating in vaccine trial, man dies in Bhopal
A 42-year-old volunteer named Deepak Marawi, from Bhopal in Madhya Pradesh died nearly ten days after he participated in the clinical trial for COVAXIN held at a private hospital, its vice-chancellor said on Saturday.
05 Jan 2021
Sleeves up! Coronavirus vaccination drive could begin on January 13
The first dose of the coronavirus vaccine in India will most likely be administered on January 13, a statement from a top official of the Union Health Ministry indicated on Tuesday.
05 Jan 2021
Global leaders hail India's scientific innovation to combat COVID-19
Global leaders have lauded India's leadership in scientific innovation and decisive action to combat the COVID-19 pandemic.
05 Jan 2021
SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.
03 Jan 2021
All you need to know about vaccines approved in India
Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.
03 Jan 2021
SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI
Two COVID-19 vaccines, Covishield and COVAXIN, have been granted emergency approval for use in India, the Drugs Controller General of India (DCGI) Dr. VG Somani said on Sunday.
03 Jan 2021
Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod
A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.
02 Jan 2021
All states to hold dry run for coronavirus vaccination today
A dry run for vaccination, before the actual doses of the coronavirus vaccine are administered to people, will be held in all states and union territories today.
01 Jan 2021
India set to start COVID-19 vaccination; panel approves Oxford vaccine
In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.
31 Dec 2020
India could start 2021 with COVID-19 vaccine in hand: DCGI
The approval for a COVID-19 vaccine in India is likely just around the corner, with the Drugs Controller General of India, Dr. VG Somani, indicating the country might begin the New Year with a vaccine in hand.
08 Dec 2020
Now, Bharat Biotech seeks emergency use approval for COVAXIN
After US-based Pfizer and Pune's Serum Institute of India, Bharat Biotech has sought an emergency use approval for its coronavirus vaccine, named COVAXIN.
06 Dec 2020
Pfizer seeks emergency approval for COVID-19 vaccine in India
United States-based pharmaceutical giant Pfizer has sought emergency approval for its COVID-19 vaccine from India's drug regulator.
31 Oct 2020
AIIMS to submit proposal for COVAXIN's phase three trials soon
By early next week, AIIMS will submit a proposal to start the third phase of clinical trials of COVAXIN, a vaccine against coronavirus being developed by Bharat Biotech.
29 Oct 2020
Oxford's coronavirus vaccine could be available by December: Adar Poonawalla
In a welcome piece of development, Serum Institute of India's CEO Adar Poonawalla said on Wednesday that the coronavirus vaccine, being developed by Oxford University, could be available for use in India by December 2020.
04 Oct 2020
Coronavirus vaccine to reach 25 crore Indians by mid-2021: Government
The Indian government is planning to provide vaccines to roughly 25 crore people by July 2021, Union Health Minister Dr. Harsh Vardhan said on Sunday.
23 Sep 2020
Bharat Biotech signs deal for nasal COVID-19 vaccine: Details here
In a major move, Bharat Biotech has signed an agreement to license a nasal COVID-19 vaccine developed by the Washington University School of Medicine in St. Louis, United States.
23 Sep 2020
NewsBytes Briefing: China won't approve TikTok deal, and more
Even as TikTok, Oracle, and Walmart came close to finalizing a deal, China is not ready to let the service off the hook.
21 Sep 2020
Coronavirus: What is the 'Feluda' test? How does it work?
The Drugs Controller General of India (DCGI) has approved for commercial launch of a CRISPR-based test for COVID-19, called 'Feluda'.
18 Aug 2020
Biocon Chief Kiran Mazumdar Shaw tests positive for coronavirus
As India reels under coronavirus catastrophe, Kiran Mazumdar Shaw, chairperson of Biocon Ltd., joined the long list of famous personalities to test positive for the highly-contagious disease.
03 Aug 2020
SII gets nod for Oxford COVID vaccine phase 2/3 trials
The Serum Institute of India (SII) has gotten the approval to conduct phase 2 and 3 human clinical trials of the COVID-19 vaccine candidate developed by Oxford University.
30 Jul 2020
Coronavirus: How much would the vaccines cost?
As the coronavirus pandemic continues to surge, all hopes rest on the development of a vaccine to beat the virus.
19 Jul 2020
You can enroll for AIIMS's COVID-19 vaccine trials: Here's how
India's indigenous COVID-19 vaccine candidate, COVAXIN, is set to go into human trials at AIIMS Delhi.
09 Jul 2020
All you need to know about India's COVID-19 vaccines
As the coronavirus outbreak continues to surge worldwide, efforts to develop a vaccine have been expedited.
07 Jul 2020
Expert panel sets conditions, ICMR's COVAXIN August-15 target looks unachievable
On July 2, the Indian Council of Medical Research (ICMR) revealed its plans to launch COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech and ICMR, by August 15.
03 Jul 2020
India's second COVID-19 vaccine cleared for human trials: Details here
India is picking up pace to develop a preventive vaccine for COVID-19, the novel coronavirus disease.
20 Jun 2020
Glenmark launches COVID-19 drug FabiFlu at Rs. 103 per tablet
Glenmark Pharmaceuticals Ltd. launched the antiviral drug favipiravir on Saturday for the treatment of mild to moderate cases of COVID-19.